I am a
Home I AM A Search Login

Papers of the Week


Papers: 13 Apr 2019 - 19 Apr 2019


Human Studies, Pharmacology/Drug Development

PAIN TYPE:
Migraine/Headache


2019 May 07


Neurology


92


19

Erenumab in chronic migraine: Patient-reported outcomes in a randomized double-blind study.

Authors

Lipton RB, Tepper SJ, Reuter U, Silberstein S, Stewart WF, Nilsen J, Leonardi DK, Desai P, Cheng S, Mikol DD, Lenz R
Neurology. 2019 May 07; 92(19):e2250-e2260.
PMID: 30996060.

Abstract

To determine the effect of erenumab, a human monoclonal antibody targeting the calcitonin gene-related peptide receptor, on health-related quality of life (HRQoL), headache impact, and disability in patients with chronic migraine (CM).